Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

Alcon and STAAR Surgical terminated their definitive merger agreement. According to a press release from STAAR, preliminary ...

STAAR Surgical said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon after failing to ...

STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR ...

Adds analyst comment, updates shares. STAAR Surgical (STAA) fell 8.3% as it plans to terminate its sale to Alcon (ALC) after ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

It appears that Staar Surgical Co.'s proposed $1.6 billion merger with Alcon AG has been scrapped as Starr shareholders voted ...

Key Insights Alcon's estimated fair value is CHF101 based on 2 Stage Free Cash Flow to Equity Alcon's CHF64.56 ...

STAAR Surgical (STAA) shareholder vote on Alcon’s (ALC) deal may be delayed again as Alcon weighs a higher offer amid opposition—read the latest update.

When Novartis said in June that it would spin off its long-struggling eye-care unit, Alcon, CEO Vas Narasimhan declined to estimate what the valuation on such a transaction might be. But his ...

STAAR Surgical is terminating its agreement to merge with Swiss eyecare specialist Alcon in a $1.6bn deal, ending a ...